UNSPSC 51131641: Nadroparin

This classification denotes a low molecular weight heparin with the molecular formula (C14H18NO11)N.2(C12H16NO13S)N.3HO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1K5KDI46KZ. European Medicines Agency schedules nadroparin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03371MIG. As of Q4 2014, NADROPARIN remains the US FDA Preferred Term for this commodity. SMILES: C(C1C(C(C(C(O1)O)NS(=O)(=O)[O-])O)OC2C(C(C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-].

UNSPSC 51131641 Nadroparin is a Commodity code for an anticoagulant pharmaceutical, but the source shows no recent state and local procurement activity actually purchasing nadroparin or related injectable anticoagulants under this code. The only recent opportunity on file — Sourcewell RFP #061626, posted May 12, 2026 with a response deadline of June 16, 2026 — solicits law enforcement equipment, which falls entirely outside the scope of pharmaceutical procurement. This mismatch between the code's nominal scope and the opportunity tagged under it signals either a data-entry error in the opportunity classification or a misunderstanding of which UNSPSC code applies to the solicitation.

Without relevant recent opportunities in the source, no characterization of issuing-body types, geographic distribution, or actual purchasing patterns under this code can be drawn. Any firm evaluating nadroparin sales to state and local health systems, prison healthcare departments, hospital purchasing cooperatives, or emergency medical services should not rely on this code's activity as a market signal. A direct search of individual state health agency solicitations, Medicaid managed care RFPs, correctional healthcare contracts, and regional healthcare purchasing consortia would be more productive.